Development of CpG-adjuvanted stable prefusion SARS-CoV-2 spike antigen as a subunit vaccine against COVID-19
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2045-2322
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Development of CpG-adjuvanted stable prefusion SARS-CoV-2 spike antigen as a subunit vaccine against COVID-19 ; volume:10 ; number:1 ; day:18 ; month:11 ; year:2020 ; pages:1-10 ; date:12.2020
Scientific reports ; 10, Heft 1 (18.11.2020), 1-10, 12.2020
- Creator
-
Kuo, Tsun-Yung
Lin, Meei-Yun
Coffman, Robert L.
Campbell, John D.
Traquina, Paula
Lin, Yi-Jiun
Liu, Luke Tzu-Chi
Cheng, Jinyi
Wu, Yu-Chi
Wu, Chung-Chin
Tang, Wei-Hsuan
Huang, Chung-Guei
Tsao, Kuo-Chien
Chen, Charles
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-020-77077-z
- URN
-
urn:nbn:de:101:1-2020122318592307449815
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:21 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Kuo, Tsun-Yung
- Lin, Meei-Yun
- Coffman, Robert L.
- Campbell, John D.
- Traquina, Paula
- Lin, Yi-Jiun
- Liu, Luke Tzu-Chi
- Cheng, Jinyi
- Wu, Yu-Chi
- Wu, Chung-Chin
- Tang, Wei-Hsuan
- Huang, Chung-Guei
- Tsao, Kuo-Chien
- Chen, Charles
- SpringerLink (Online service)
Other Objects (12)
Adjuvanted infuenza vaccine dynamics
Adjuvanted influenza vaccine dynamics
Safety and immunogenicity of an MF59™-adjuvanted subunit influenza vaccine in elderly Chinese subjects
A CpG 1018 adjuvanted neuraminidase vaccine provides robust protection from influenza virus challenge in mice
Post-Marketing Safety Surveillance for the Adjuvanted Recombinant Zoster Vaccine: Methodology
Down selecting adjuvanted vaccine formulations: a comparative method for harmonized evaluation
Intranasal immunization with a proteosome-adjuvanted SARS-CoV-2 spike protein-based vaccine is immunogenic and efficacious in mice and hamsters
A variant-proof SARS-CoV-2 vaccine targeting HR1 domain in S2 subunit of spike protein
Mucosal immunization with a delta-inulin adjuvanted recombinant spike vaccine elicits lung-resident immune memory and protects mice against SARS-CoV-2
Skin manifestations after immunisation with an adjuvanted recombinant zoster vaccine, Germany, 2020
A CpG-adjuvanted intranasal enterovirus 71 vaccine elicits mucosal and systemic immune responses and protects human SCARB2-transgenic mice against lethal challenge
Comment on “Cost-Effectiveness Analysis of Herpes Zoster Vaccination in 50- to 85-Year-Old Immunocompetent Belgian Cohorts: A Comparison between No Vaccination, the Adjuvanted Subunit Vaccine, and Live-Attenuated Vaccine”
Adjuvanted infuenza vaccine dynamics
Adjuvanted influenza vaccine dynamics
Safety and immunogenicity of an MF59™-adjuvanted subunit influenza vaccine in elderly Chinese subjects
A CpG 1018 adjuvanted neuraminidase vaccine provides robust protection from influenza virus challenge in mice
Post-Marketing Safety Surveillance for the Adjuvanted Recombinant Zoster Vaccine: Methodology
Down selecting adjuvanted vaccine formulations: a comparative method for harmonized evaluation
Intranasal immunization with a proteosome-adjuvanted SARS-CoV-2 spike protein-based vaccine is immunogenic and efficacious in mice and hamsters
A variant-proof SARS-CoV-2 vaccine targeting HR1 domain in S2 subunit of spike protein
Mucosal immunization with a delta-inulin adjuvanted recombinant spike vaccine elicits lung-resident immune memory and protects mice against SARS-CoV-2
Skin manifestations after immunisation with an adjuvanted recombinant zoster vaccine, Germany, 2020
A CpG-adjuvanted intranasal enterovirus 71 vaccine elicits mucosal and systemic immune responses and protects human SCARB2-transgenic mice against lethal challenge
Comment on “Cost-Effectiveness Analysis of Herpes Zoster Vaccination in 50- to 85-Year-Old Immunocompetent Belgian Cohorts: A Comparison between No Vaccination, the Adjuvanted Subunit Vaccine, and Live-Attenuated Vaccine”
Adjuvanted infuenza vaccine dynamics
Adjuvanted influenza vaccine dynamics
Safety and immunogenicity of an MF59™-adjuvanted subunit influenza vaccine in elderly Chinese subjects
A CpG 1018 adjuvanted neuraminidase vaccine provides robust protection from influenza virus challenge in mice
Post-Marketing Safety Surveillance for the Adjuvanted Recombinant Zoster Vaccine: Methodology
Down selecting adjuvanted vaccine formulations: a comparative method for harmonized evaluation
Intranasal immunization with a proteosome-adjuvanted SARS-CoV-2 spike protein-based vaccine is immunogenic and efficacious in mice and hamsters
A variant-proof SARS-CoV-2 vaccine targeting HR1 domain in S2 subunit of spike protein
Mucosal immunization with a delta-inulin adjuvanted recombinant spike vaccine elicits lung-resident immune memory and protects mice against SARS-CoV-2
Skin manifestations after immunisation with an adjuvanted recombinant zoster vaccine, Germany, 2020
A CpG-adjuvanted intranasal enterovirus 71 vaccine elicits mucosal and systemic immune responses and protects human SCARB2-transgenic mice against lethal challenge